コンテンツにスキップ

Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition

著者 :
Edited by Bradley A. Mcgregor, MD and Toni K. Choueiri
In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the cente ...view more
In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more.
ISBNコード :
9780323938990
出版日 :
15-09-2023
カートに入れる

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more.

特長
  • Contains 18 relevant, practice-oriented topics including the role of surgery in metastatic renal cell cancer; emerging biomarkers in metastatic renal cell cancer; choosing the right treatment for renal cell cancer of variant histology; novel targets in the treatment of renal cell cancer; and more.

  • Provides in-depth clinical reviews on renal cell cancer, offering actionable insights for clinical practice.

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.


著者情報
Edited by Bradley A. Mcgregor, MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Toni K. Choueiri, Jerome and Nancy Kohlberg Professor, Medicine, Harvard Medical School, Attending Physician, Solid Tumor Oncology, Dana-Farber Cancer Institute, Director, Genitourinary (GU) Oncology Disease Center,Dana-Farber Cancer Institute
詳細情報
ISBN Number 9780323938990
Description Author List Edited by Bradley A. Mcgregor, MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Toni K. Choueiri, Jerome and Nancy Kohlberg Professor, Medicine, Harvard Medical School, Attending Physician, Solid Tumor Oncology, Dana-Farber Cancer Institute, Director, Genitourinary (GU) Oncology Disease Center,Dana-Farber Cancer Institute
Copyright Year 2023
Edition Number 1
Format Book
Trim 152w x 229h (6.00" x 9.00")
Imprint Elsevier
Page Count 240
Publication Date 15 Sep 2023
Stock Status IN STOCK

eBooks : Built for busy schedules & tailored for your goals.

Affordable knowledge, built for you

Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.

Seamless access wherever you are

Open your eBook on your laptop, tablet, or phone - online or offline. Learning fits into your life, no matter where you go.

Always in sync

Start reading on one device and pick up right where you left off on another. Your progress and notes stay with you, every step of the way.

Tools the make learning stick

Highlight key points, take notes, create flashcards, or listen to your eBook read aloud. Interactive features help you deepen your knowledge, your way.

 

Your eBook is ready whenever you are!

1.  Check your email for your access code.

2.  Sign into or create your VitalSource account and redeem your code.

3.  Open your eBook - ready whenever you are!

FAQ

The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.


Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.


The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.


You will have unlimited access to your eBook on the device to which it was downloaded.


Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.


Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.


Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.


You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.

Any questions ?

Support Center >

Top Picks from Our Community

von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma
Hereditary Renal Cell Carcinoma Syndromes
The Role of the Pathologist in Renal Cell Carcinoma Management
Insights into Renal Cell Carcinoma with Novel Imaging Approaches
Surgical Management of Localized Disease and Small Renal Masses
Role of Surgery in Metastatic Renal Cell Carcinoma
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Role of Radiation in Treatment of Renal Cell Carcinoma
Prognostic Models in Metastatic Renal Cell Carcinoma
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma
Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy
Renal Cell Carcinoma of Variant Histology: Biology and Therapies
Toxicity Management of Systemic Kidney Cancer Therapies
Management of Brain Metastases in Metastatic Renal Cell Carcinoma
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
あなたのレビューを投稿する
登録ユーザーのみがレビューを書くことができます。 ログインするか、アカウントを作成してください